Bausch + Lomb Corporation ( BLCO) - Key Metrics
BLCO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.89 | -$0.04 | $0.43 | $0.23 |
| 2026Q1 | $3.50 | -$0.20 | $0.09 | -$0.19 |
| 2025Q4 | $3.96 | -$0.16 | $0.38 | $0.17 |
| 2025Q3 | $3.62 | -$0.08 | $0.39 | $0.18 |
| 2025Q2 | $3.61 | -$0.18 | $0.10 | -$0.15 |
BLCO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -105.61 |
| 2026Q1 | 0% | -19.88 |
| 2025Q4 | 0% | -26.69 |
| 2025Q3 | 0% | -47.69 |
| 2025Q2 | 0% | -18.07 |
BLCO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.39% | 0% |
| 2026Q1 | -1.20% | 0% |
| 2025Q4 | 1.02% | 0% |
| 2025Q3 | 1.21% | 0% |
| 2025Q2 | -1.17% | 0% |
BLCO
Price: $17.11
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Volume: 494000
Market Capitalization: 6.4 billion